The burden of both objective and subjective obstructive sleep apnea improved more in patients who received upper airway stimulation compared with those who did not.
The rates of myocardial infarction were found to decline during the COVID-19 pandemic, which also saw increases in sleep duration.
Any prenatal cannabis use was associated with symptoms of disorders of initiating and maintaining sleep.
Positive topline results were announced from the second pivotal phase 3 study evaluating daridorexant (Idorsia), an investigational dual orexin receptor antagonist, for the treatment of insomnia.
Heightened cognitive arousal at bedtime is linked to objective sleep disturbances and indicators of psychological hyperarousal at night and during the day.
Some behavioral sleep problems in early childhood are associated with the onset of mental health symptoms during early adolescence.
Rhythmic movement disorder is a rare motor disorder that results in frequent night sleep disturbances.
Among adults without a clinical diagnosis of ADHD, heavy alcohol use predicted more severe ADHD symptoms.
Nearly half of pregnant women suffer from poor quality sleep, particularly in the third trimester, and poor sleep is associated with an increased risk of preterm delivery and postnatal depression.
The bidirectional relationship between migraine and sleep disorders are examined in this article.
Dayvigo (lemborexant; Eisai) is now available for the treatment of insomnia characterized by difficulties with sleep onset and/or sleep maintenance in adult patients.
Sleep-onset problems in the first year of life may precede an autism spectrum disorder diagnosis in children at higher risk for ASD.
Sleep-disordered breathing and fragmented sleep are associated with higher levels of fasting glucose and hemoglobin A1c in black adults.
While carefully timed light exposure may address sleep problems associated with circadian rhythm disturbances, studies that examine light therapies in the context of sleep disorders have been largely lacking in measures of adherence and acceptability of these approaches.
More than one-third of medical staff members in hospitals during the COVID-19 outbreak in China reported insomnia symptoms.
Idorsia announced positive topline results from a phase 3 study of daridorexant, an investigational dual orexin receptor antagonist, for the treatment of insomnia.
Depression and anxiety were significantly associated with sleep difficulties, including trouble falling asleep, early waking, coughing or snoring, feeling too cold or too hot, and having a bad dream.
The FDA has issued new guidance regarding the use of computerized behavioral therapy and other digital health therapeutic devices for psychiatric disorders during the coronavirus disease 2019 (COVID-19) pandemic.
The presence of migraine and increasing headache pain intensity are associated with higher rates of anxiety, depression, inflammation, and sleep conditions, among other disorders.
Depression is twice as common in patients with chronic pain compared to health subjects, and pain intensity, frequency, and number of locations are linked to depression and anxiety.